ORTHOPEDIATRICS CORP Net Income Loss

Quick Answer

ORTHOPEDIATRICS CORP reported Net Income Loss of -$39.65 million for the year ending 2025.

  • ORTHOPEDIATRICS CORP showed a decrease of -4.8% in Net Income Loss from 2024 to 2025.
  • This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), ORTHOPEDIATRICS CORP's Net Income Loss has declined by 402.4%.
  • Historical annual values: Fiscal year 2025: -$39.65 million | Fiscal year 2024: -$37.82 million | Fiscal year 2023: -$20.97 million | Fiscal year 2022: $1.26 million | Fiscal year 2021: -$16.26 million | Fiscal year 2020: -$32.94 million | Fiscal year 2019: -$13.73 million | Fiscal year 2018: -$12.03 million | Fiscal year 2017: -$8.93 million | Fiscal year 2016: -$6.57 million | Fiscal year 2015: -$7.89 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: